Literature DB >> 12524443

Insulin receptor substrate 1 regulation of sarco-endoplasmic reticulum calcium ATPase 3 in insulin-secreting beta-cells.

Prabhakar D Borge1, Bryan A Wolf.   

Abstract

We have previously characterized an insulin receptor substrate 1 (IRS-1)-overexpressing beta-cell line. These beta-cells demonstrated elevated fractional insulin secretion and elevated cytosolic Ca(2+) levels compared with wild-type and vector controls. This effect of IRS-1 may be mediated via an interaction with the sarco-endoplasmic reticulum calcium ATPase (SERCA). Here we demonstrate that IRS-1 and IRS-2 localize to an endoplasmic reticulum (ER)-enriched fraction in beta-cells using subcellular fractionation. We also observe co-localization of both IRS-1 and IRS-2 with ER marker proteins using immunofluorescent confocal microscopy. Furthermore, immuno-electron microscopy studies confirm that IRS-1 and SERCA3b localize to vesicles derived from the ER. In Chinese hamster ovary-T (CHO-T) cells transiently transfected with SERCA3b alone or together with IRS-1, SERCA3b co-immunoprecipitates with IRS-1. This interaction is enhanced with insulin treatment. SERCA3b also co-immunoprecipitates with IRS-1 in wild-type and IRS-1-overexpressing beta-cell lines. Ca(2+) uptake in ER-enriched fractions prepared from wild-type and IRS-1-overexpressing cell lines shows no significant difference, indicating that the previously observed decrease in Ca(2+) uptake by IRS-1-overexpressing cells is not the result of a defect in SERCA. Treatment of wild-type beta-cells with thapsigargin, an inhibitor of SERCA, resulted in an increase in glucose-stimulated fractional insulin secretion similar to that observed in IRS-1-overexpressing cells. The colocalization of IRS proteins and SERCA in the ER of beta-cells increases the likelihood that these proteins can interact with one another. Co-immunoprecipitation of IRS-1 and SERCA in CHO-T cells and beta-cells confirms that these proteins do indeed interact directly. Pharmacological inhibition of SERCA in beta-cells results in enhanced secretion of insulin. Taken together, our data suggest that interaction between IRS proteins and SERCA is an important regulatory step in insulin secretion.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12524443     DOI: 10.1074/jbc.M209521200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

Review 1.  Endoplasmic-reticulum calcium depletion and disease.

Authors:  Djalila Mekahli; Geert Bultynck; Jan B Parys; Humbert De Smedt; Ludwig Missiaen
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-06-01       Impact factor: 10.005

Review 2.  β-Cell Receptor Tyrosine Kinases in Controlling Insulin Secretion and Exocytotic Machinery: c-Kit and Insulin Receptor.

Authors:  Amanda Oakie; Rennian Wang
Journal:  Endocrinology       Date:  2018-11-01       Impact factor: 4.736

3.  Expression of sarco (endo) plasmic reticulum calcium ATPase (SERCA) system in normal mouse cardiovascular tissues, heart failure and atherosclerosis.

Authors:  Larissa Lipskaia; Zela Keuylian; Karl Blirando; Nathalie Mougenot; Adeline Jacquet; Clotilde Rouxel; Haifa Sghairi; Ziane Elaib; Regis Blaise; Serge Adnot; Roger J Hajjar; Elie R Chemaly; Isabelle Limon; Regis Bobe
Journal:  Biochim Biophys Acta       Date:  2014-08-07

4.  Ca2+-ATPases in non-failing and failing heart: evidence for a novel cardiac sarco/endoplasmic reticulum Ca2+-ATPase 2 isoform (SERCA2c).

Authors:  Saoussen Dally; Raymonde Bredoux; Elisabeth Corvazier; Jens P Andersen; Johannes D Clausen; Leonard Dode; Mohammed Fanchaouy; Pascal Gelebart; Virginie Monceau; Frederica Del Monte; Judith K Gwathmey; Roger Hajjar; Chiraz Chaabane; Régis Bobe; Aly Raies; Jocelyne Enouf
Journal:  Biochem J       Date:  2006-04-15       Impact factor: 3.857

5.  Pancreatic deletion of insulin receptor substrate 2 reduces beta and alpha cell mass and impairs glucose homeostasis in mice.

Authors:  J Cantley; A I Choudhury; H Asare-Anane; C Selman; S Lingard; H Heffron; P Herrera; S J Persaud; D J Withers
Journal:  Diabetologia       Date:  2007-03-29       Impact factor: 10.122

6.  Insulin acutely increases agonist-induced airway smooth muscle contraction in humans and rats.

Authors:  Becky J Proskocil; Gina N Calco; Zhenying Nie
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2021-01-27       Impact factor: 5.464

7.  Sensory neurons derived from diabetic rats have diminished internal Ca2+ stores linked to impaired re-uptake by the endoplasmic reticulum.

Authors:  Elena Zherebitskaya; Jason Schapansky; Eli Akude; Darrell R Smith; Randy Van der Ploeg; Natasha Solovyova; Alexei Verkhratsky; Paul Fernyhough
Journal:  ASN Neuro       Date:  2012-01-18       Impact factor: 4.146

Review 8.  The Novel Functions of High-Molecular-Mass Complexes Containing Insulin Receptor Substrates in Mediation and Modulation of Insulin-Like Activities: Emerging Concept of Diverse Functions by IRS-Associated Proteins.

Authors:  Fumihiko Hakuno; Toshiaki Fukushima; Yosuke Yoneyama; Hiroyasu Kamei; Atsufumi Ozoe; Hidehito Yoshihara; Daisuke Yamanaka; Takashi Shibano; Meri Sone-Yonezawa; Bu-Chin Yu; Kazuhiro Chida; Shin-Ichiro Takahashi
Journal:  Front Endocrinol (Lausanne)       Date:  2015-05-26       Impact factor: 5.555

9.  Phosphoenolpyruvate Is a Metabolic Checkpoint of Anti-tumor T Cell Responses.

Authors:  Ping-Chih Ho; Jessica Dauz Bihuniak; Andrew N Macintyre; Matthew Staron; Xiaojing Liu; Robert Amezquita; Yao-Chen Tsui; Guoliang Cui; Goran Micevic; Jose C Perales; Steven H Kleinstein; E Dale Abel; Karl L Insogna; Stefan Feske; Jason W Locasale; Marcus W Bosenberg; Jeffrey C Rathmell; Susan M Kaech
Journal:  Cell       Date:  2015-08-27       Impact factor: 41.582

10.  IRS1 deficiency protects β-cells against ER stress-induced apoptosis by modulating sXBP-1 stability and protein translation.

Authors:  Tomozumi Takatani; Jun Shirakawa; Michael W Roe; Colin A Leech; Bernhard F Maier; Raghavendra G Mirmira; Rohit N Kulkarni
Journal:  Sci Rep       Date:  2016-07-05       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.